Key result
Variant angina links to lower 6-keto PGF1 alpha, while obstructive CAD links to higher TXB2.
Why the study?
The contribution of prostanoids in coronary spasm in patients with variant angina was unclear.
Are plasma levels of TXB2 and 6-keto PGF1 alpha altered in patients with variant angina compared to those with effort angina and normal controls?
Observational (n=54)
Are plasma levels of TXB2 and 6-keto PGF1 alpha altered in patients with variant angina compared to those with effort angina and normal controls?
Low levels of prostacyclin (PGI2) and high levels of thromboxane A2 may contribute to the pathogenesis of coronary spasm in patients with variant angina.
TXB2 differences in effort angina are hypothesis-generating; leaves open prostanoid role in spasm pending prospective confirmation.
Plasma levels of thromboxane B2 (TXB2) and 6-keto PGF1 alpha in the blood samples taken at the coronary sinus and ascending aorta from twenty-one Japanese patients with variant angina and twenty with effort angina were measured by radioimmunoassay, the objective being to search for the contribution of prostanoids in coronary spasm. The data were compared with data on thirteen subjects free from coronary artery diseases. In coronary sinus blood, plasma TXB2 in patients with effort angina exhibited statistically significant high levels, as compared with data in the controls. These with variant angina also had high levels, albeit without a statistically significant difference. Eight patients with variant angina and for whom the coronary angiogram showed more than 50% of narrowing had statistically significant high levels of TXB2, and the other thirteen with variant angina and normal coronaries or less than 50% of narrowing had the same plasma levels of TXB2 as the controls. In contrast to TXB2, the plasma levels of 6-keto PGF1 alpha in both coronary sinus and aortic blood of patients with variant angina were very low, as compared with normal controls. Statistically significant low levels of 6-keto PGF1 alpha were noted in the coronary sinus blood of patients with variant angina with normal coronaries and in the aortic blood of those with variant angina, as compared with data on the normal controls. Neither ergonovine test nor spontaneous attacks in patients with variant angina revealed characteristic changes in levels of TXB2 and 6-keto PGF1 alpha in the coronary sinus. These data suggest that high levels of TXB2 in patients with atherosclerotic coronaries may be one factor leading to spasm, while low levels of PGI2 may be a contributing factor.
No takes yet. Share an insight, caveat, or question.
Numano et al. (1985) conducted an observational in Variant angina and effort angina (n=54). Variant angina and effort angina vs. Subjects free from coronary artery diseases was evaluated on Plasma levels of thromboxane B2 (TXB2) and 6-keto PGF1 alpha. Patients with variant angina had significantly lower plasma levels of 6-keto PGF1 alpha compared to controls, while those with >50% coronary narrowing had significantly higher TXB2 levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: